Vials with a sticker studying, ‘COVID-19 / Coronavirus vaccine / Injection solely’ and a medical syringe are seen in entrance of a displayed Pfizer emblem on this illustration taken October 31, 2020. (Image: Reuters)
Every nation that has a drug regulatory company must situation its personal approval for any COVID-19 vaccine, however international locations with weak programs normally depend on WHO to vet the photographs.
- Associated Press Geneva
- Last Updated: January 01, 2021, 07:12 IST
- FOLLOW US ON:
The World Health Organization says it has cleared the Pfizer-BioNTech coronavirus vaccine for emergency use, that means poorer international locations could quickly get entry to the shot already accessible in Europe and North America. Every nation that has a drug regulatory company must situation its personal approval for any COVID-19 vaccine, however international locations with weak programs normally depend on WHO to vet the photographs.
The world physique stated late Thursday that the choice to situation its first emergency use validation for a COVID-19 vaccine “opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine.” The UN well being company stated its overview discovered the Pfizer-BioNTech vaccine, which has already acquired clearance within the United States, Britain, the European Union and a dozen different international locations, “met the must-have criteria for safety and efficacy set out by WHO.”
The BioNTech-Pfizer vaccine must be saved at ultra-frozen temperatures, an enormous hurdle for growing international locations the place the required freezers and dependable electrical energy provide will not be accessible. “This requirement makes the vaccine more challenging to deploy in settings where ultra-cold chain equipment may not be available or reliably accessible,” WHO stated, including that it was “working to support countries in assessing their delivery plans and preparing for use where possible”.